How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

ZE

OOTC:ZENO
Get a brief AI stock analysisSaves ~ 15 minutes of your time

ZE

Zenosense IncOOTC ZENO Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is ZENO undervalued compared to its fair value?

The fair value of ZENO stock is hidden USD. Relative to the market price of 0 USD Zenosense Inc is hidden.

Zenosense, Inc. (Zenosense) is focused on commencing the business of developing specialized and non-invasive disease sensory devices. The Company's focus is on products designed to detect methicillin resistant Staphyloco...[More about valuation]

Zenosense Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.005

FINANCIALS

Zenosense financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

-0.0016 B

Financial Position Analysis

0

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Zenosense fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ZENO attractive for investment based on fundamental analysis?

ZENO stock rating is hidden. Zenosense is a hidden by Eyestock methodology.

Get ZENO Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ZENO analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ZENO to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Zenosense Inc competitors

BH

BHARTIHEXA.NS

Bharti Hexacom Ltd

Bharti Hexacom Ltd is a IN-based company operating in industry. The company is headquartered in New Delhi, Delhi. The company went IPO on 2024-04-12. Bharti Hexacom Limited is a c...

Discover

SY

SYM

Symbotic Inc

Symbotic Inc is a US-based company operating in industry. The company is headquartered in San Carlos, California. SVF Investment Corp. 3 is a blank check company. The firm is inc...

Discover

VS

VSBC

Vitaspring Biomedical Co. Ltd

VitaSpring Biomedical Co. Ltd. engages in the research and development of stem cell applications in regenerative medicine and the establishment of advanced medical research centers...

Discover

Zenosense Inc dividends

ZENO dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ZENO stock

About the company Zenosense Inc

Market cap $B

0

Dividend yield

Shares outstanding

31.93 B

Website

Zenosense, Inc. (Zenosense) is focused on commencing the business of developing specialized and non-invasive disease sensory devices. The Company's focus is on products designed to detect methicillin resistant Staphylococcus aureus (MRSA) /Staphylococcus aureus (SA) when present in healthcare environments and to detect the presence of lung cancer in a patient. The Company's product is focused on sampling the air and continuously monitoring the airborne, the volatile organic compounds (VOCs) signatures emitted, by MRSA/SA. The Company's device with a single sensor is focused on performing the entire VOC spectrum scan, as the adaptive processing software enables it to perform various scans, creating multiple virtual sensors from a single sensor. The Company's device is intended to be produced in two forms: a wearable/bed-positioned device and an adapted, fixed device positioned in the room.

ZENO profile

  • Ticker

    ZENO

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    19 June 2013

  • Sector

    Others

  • Industry

    Others

  • Employees

  • City

    New Haven

  • Address

    400 Blake St.

  • Cusip

    989424205